In summary, we described the critical role of NEDD4-1 in regulating the redox imbalance in TMZ-resistant GBM cells through the degradation of PTEN, the regulator of the AKT/NRF2/HO-1 signaling pathway. Here, PTEN is linked to glioblastoma.